Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Glucose and Oxygen Availability Shape Growth and Architecture of Tumor Spheroids in a Microfluidic 3D Model.

Created on 11 Oct 2026

Authors

Paula Guerrero-López, Jose Manuel Garcia-Aznar

Published in

Annals of biomedical engineering. Oct 11, 2026. Epub Oct 11, 2026.

Abstract

Glucose and oxygen availability are fundamental drivers of tumor progression, deeply influencing cancer cell proliferation, metabolism, and spatial organization. In this study, we present a simplified microfluidic-based 3D model of tumorigenesis that allows for controlled and dynamic analysis of key tumor parameters under metabolic stress. Using this platform, lung adenocarcinoma (A549) spheroids embedded in a collagen-based extracellular matrix were monitored over time to assess growth kinetics, hypoxic response via HIF-1α expression, and structural organization. A multifactorial experimental design combining variations in glucose, glutamine, and oxygen availability revealed distinct and specific effects of each nutrient. Glutamine deprivation led to widespread cell death, while glucose limitation strongly arrests cell proliferation. Finally, oxygen restriction disrupted spheroid architecture, resulting in loss of the proliferative outer capsule and the formation of internal cavities. Our approach provides a flexible system to study how microenvironmental cues shape tumor behavior, offering insights into metabolic vulnerabilities and the morphofunctional consequences of nutrient stress in cancer.

PMID:
42859951
Bibliographic data and abstract were imported from PubMed on 11 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement